In 2012, Myamoto et al. [87] classified CTCs obtained from PCa patients as “AR-on” or “AR-off” whether CTCs expressed PSA without PSMA (AR-on) or PSMA without PSA (AR-off). The gene discussed is AR; the disease is posterior cortical atrophy.